Alterity Therapeutics (ATHE) Assets Average (2009 - 2025)
Alterity Therapeutics (ATHE) posted quarterly Assets Average of $33.4 million for Q4 2025, up 241.65% year-over-year from $9.8 million in Q4 2024, and up 83.78% quarter-over-quarter from $18.2 million in Q2 2025.
Alterity Therapeutics (ATHE) Assets Average (2009 - 2025) Analysis & Trends
Alterity Therapeutics' Assets Average history runs 17 years deep, the most recent figure standing at $33.4 million for Q4 2025.
- In Q4 2025, Assets Average rose 241.65% year-over-year to $33.4 million; the TTM figure through Dec 2025 stood at $33.4 million (up 241.65% YoY), while the FY2023 annual figure was $24.1 million, down 13.61% from the prior year.
- Assets Average for Q4 2025 stood at $33.4 million, up from $18.2 million in the prior quarter.
- The five-year high for Assets Average was $33.4 million in Q4 2025, with the low at $7.4 million in Q4 2023.
- The 5-year median for Assets Average is $22.0 million (2022), against an average of $20.6 million.
- The sharpest annual moves came in 2023 and 2025: Assets Average slumped 71.45% in 2023, then soared 241.65% in 2025.
- Alterity Therapeutics' Assets Average stood at $29.3 million in 2021, then dropped by 12.01% to $25.8 million in 2022, then tumbled by 71.45% to $7.4 million in 2023, then soared by 32.92% to $9.8 million in 2024, then jumped by 241.65% to $33.4 million in 2025.
- Business Quant data shows ATHE's Assets Average at $33.4 million in Q4 2025, $18.2 million in Q2 2025, and $9.8 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.61 Bn | 131.75 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 65.28 Bn | 60.09 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.14 Bn | 54.00 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 42.13 Bn | 37.03 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.83 Bn | 28.52 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 19.82 Bn |
| 10 | Alterity Therapeutics | 49.04 Mn | 16.74 Mn | - | 33.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 33.42 Mn |
| Jun 30, 2025 | 18.19 Mn |
| Dec 31, 2024 | 9.78 Mn |
| Jun 30, 2024 | 13.56 Mn |
| Dec 31, 2023 | 7.36 Mn |
| Jun 30, 2023 | 11.10 Mn |
| Dec 31, 2022 | 25.78 Mn |
| Jun 30, 2022 | 31.18 Mn |
| Dec 31, 2021 | 29.30 Mn |
| Jun 30, 2021 | 26.60 Mn |
| Dec 31, 2020 | 16.92 Mn |
| Jun 30, 2020 | 8.20 Mn |
| Dec 31, 2019 | 11.92 Mn |
| Jun 30, 2019 | 5.08 Bn |
| Dec 31, 2018 | 5.08 Bn |
| Jun 30, 2018 | 15.52 Mn |
| Dec 31, 2017 | 9.50 Bn |
| Jun 30, 2017 | 9.51 Bn |
| Dec 31, 2016 | 12.60 Bn |
| Jun 30, 2016 | 12.61 Bn |